Sanara MedTech Inc. Common Stock SMTI

$34.15 -0.03% at last close

Analyst Consensus

Consensus Rating
Moderate Buy (2 Buy · 1 Hold · 0 Sell)
Average Price Target
$34.00
Implied Upside
-0.4%
Price Target Range
$32.00 – $35.00
Analysts (12 mo)
3

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-07-30
HC Wainwright & Co.Yi Chen
Downgrades Buy → Neutral $36 → $35
2026-06-17
Freedom BrokerIlya Zubkov
Initiates coverage on Buy $35
2026-04-15
Lake StreetFrank Takkinen
Initiates coverage on Buy $32
2026-01-26
HC Wainwright & Co.Yi Chen
Reiterates Buy $36
2025-11-14
HC Wainwright & Co.Yi Chen
Maintains Buy $54 → $36
2025-08-18
HC Wainwright & Co.Yi Chen
Maintains Buy $53 → $54
2025-05-15
HC Wainwright & Co.Yi Chen
Maintains Buy $51 → $53
2025-03-26
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $46
2025-03-26
HC Wainwright & Co.Yi Chen
Maintains Buy $50 → $51
2025-01-23
HC Wainwright & Co.Yi Chen
Reiterates Buy $50
2025-01-23
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $44
2024-12-23
HC Wainwright & Co.Yi Chen
Initiates coverage on Buy $50
2024-05-15
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $44
2024-03-27
Cantor FitzgeraldRoss Osborn
Maintains Overweight $49 → $44
2024-02-06
Cantor FitzgeraldRoss Osborn
Reiterates Overweight $49
2023-11-15
Cantor FitzgeraldRoss Osborn
Maintains Overweight $59 → $49
2023-09-26
Cantor FitzgeraldBrandon Folkes
Reiterates Overweight $59
2023-08-22
Cantor FitzgeraldBrandon Folkes
Reiterates Overweight $59
2023-08-17
Cantor FitzgeraldBrandon Folkes
Reiterates Overweight $59
2021-06-30
Cantor FitzgeraldBrandon Folkes
Initiates coverage on Overweight $45

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$34.15
Market Cap
$313.77 million
52-Week Range
$16.05 $35.95
Average Volume
297K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.